|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Herbst RS, Heymach JV and Lippman SM: Lung
cancer. N Engl J Med. 359:1367–1380. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Calin GA, Sevignani C, Dumitru CD, et al:
Human microRNA genes are frequently located at fragile sites and
genomic regions involved in cancers. Proc Natl Acad Sci USA.
101:2999–3004. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Johnson CD, Esquela-Kerscher A, Stefani G,
et al: The let-7 microRNA represses cell proliferation pathways in
human cells. Cancer Res. 67:7713–7722. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kumar MS, Erkeland SJ, Pester RE, et al:
Suppression of non-small cell lung tumor development by the let-7
microRNA family. Proc Natl Acad Sci USA. 105:3903–3908. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Takamizawa J, Konishi H, Yanagisawa K, et
al: Reduced expression of the let-7 microRNAs in human lung cancers
in association with shortened postoperative survival. Cancer Res.
64:3753–3756. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lin PY, Yu SL and Yang PC: MicroRNA in
lung cancer. Br J Cancer. 103:1144–1148. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Liu J, Carmell MA, Rivas FV, et al:
Argonaute2 is the catalytic engine of mammalian RNAi. Science.
305:1437–1441. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Croce CM: Causes and consequences of
microRNA dysregulation in cancer. Nat Rev Genet. 10:704–714. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu X, Sempere LF, Galimberti F, et al:
Uncovering growth-suppressive MicroRNAs in lung cancer. Clin Cancer
Res. 15:1177–1183. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ando T, Yoshida T, Enomoto S, et al: DNA
methylation of microRNA genes in gastric mucosae of gastric cancer
patients: its possible involvement in the formation of epigenetic
field defect. Int J Cancer. 124:2367–2374. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Shimizu T, Suzuki H, Nojima M, et al:
Methylation of a panel of microRNA genes is a novel biomarker for
detection of bladder cancer. Eur Urol. 63:1091–1100. 2013.
View Article : Google Scholar
|
|
14
|
Lv XB, Jiao Y, Qing Y, et al: miR-124
suppresses multiple steps of breast cancer metastasis by targeting
a cohort of pro-metastatic genes in vitro. Chin J Cancer.
30:821–830. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang J, Lu Y, Yue X, et al: MiR-124
suppresses growth of human colorectal cancer by inhibiting STAT3.
PLoS One. 8:e703002013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wei J, Wang F, Kong LY, et al: miR-124
inhibits STAT3 signaling to enhance T cell-mediated immune
clearance of glioma. Cancer Res. 73:3913–3926. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Grivennikov SI and Karin M: Dangerous
liaisons: STAT3 and NF-kappaB collaboration and crosstalk in
cancer. Cytokine Growth Factor Rev. 21:11–19. 2010. View Article : Google Scholar :
|
|
18
|
Zhang X, Zhang J, Wang L, Wei H and Tian
Z: Therapeutic effects of STAT3 decoy oligodeoxynucleotide on human
lung cancer in xenograft mice. BMC Cancer. 7:1492007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kanda N, Seno H, Konda Y, et al: STAT3 is
constitutively activated and supports cell survival in association
with survivin expression in gastric cancer cells. Oncogene.
23:4921–4929. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yang G, Huang C, Cao J, Huang KJ, Jiang T
and Qiu ZJ: Lentivirus-mediated shRNA interference targeting STAT3
inhibits human pancreatic cancer cell invasion. World J
Gastroenterol. 15:3757–3766. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ikari A, Sato T, Watanabe R, Yamazaki Y
and Sugatani J: Increase in claudin-2 expression by an
EGFR/MEK/ERK/c-Fos pathway in lung adenocarcinoma A549 cells.
Biochim Biophys Acta. 1823:1110–1118. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Peltier HJ and Latham GJ: Normalization of
microRNA expression levels in quantitative RT-PCR assays:
identification of suitable reference RNA targets in normal and
cancerous human solid tissues. RNA. 14:844–852. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Howington JA, Blum MG, Chang AC, Balekian
AA and Murthy SC: Treatment of stage I and II non-small cell lung
cancer: diagnosis and management of lung cancer, 3rd ed: American
College of Chest Physicians evidence-based clinical practice
guidelines. Chest. 143:e278S–313S. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Raveche ES, Salerno E, Scaglione BJ, et
al: Abnormal microRNA-16 locus with synteny to human 13q14 linked
to CLL in NZB mice. Blood. 109:5079–5086. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hatley ME, Patrick DM, Garcia MR, et al:
Modulation of K-Ras-dependent lung tumorigenesis by MicroRNA-21.
Cancer Cell. 18:282–293. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Clark AM, Goldstein LD, Tevlin M, Tavare
S, Shaham S and Miska EA: The microRNA miR-124 controls gene
expression in the sensory nervous system of Caenorhabditis elegans.
Nucleic Acids Res. 38:3780–3793. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Fowler A, Thomson D, Giles K, et al:
miR-124a is frequently down-regulated in glioblastoma and is
involved in migration and invasion. Eur J Cancer. 47:953–963. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li KK, Pang JC, Ching AK, et al: miR-124
is frequently downregulated in medulloblastoma and is a negative
regulator of SLC16A1. Hum Pathol. 40:1234–1243. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lv Z and Yang L: MiR-124 inhibits the
growth of glioblastoma through the downregulation of SOS1. Mol Med
Rep. 8:345–349. 2013.PubMed/NCBI
|
|
30
|
Zheng F, Liao YJ, Cai MY, et al: The
putative tumour suppressor microRNA-124 modulates hepatocellular
carcinoma cell aggressiveness by repressing ROCK2 and EZH2. Gut.
61:278–289. 2012. View Article : Google Scholar
|
|
31
|
Hatziapostolou M, Polytarchou C, Aggelidou
E, et al: An HNF4alpha-miRNA inflammatory feedback circuit
regulates hepatocellular oncogenesis. Cell. 147:1233–1247. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Han ZB, Yang Z, Chi Y, et al: MicroRNA-124
suppresses breast cancer cell growth and motility by targeting
CD151. Cell Physiol Biochem. 31:823–832. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang P, Chen L, Zhang J, et al:
Methylation-mediated silencing of the miR-124 genes facilitates
pancreatic cancer progression and metastasis by targeting Rac1.
Oncogene. 33:514–524. 2014. View Article : Google Scholar
|
|
34
|
Zhao WH, Wu SQ and Zhang YD:
Downregulation of miR-124 promotes the growth and invasiveness of
glioblastoma cells involving upregulation of PPP1R13L. Int J Mol
Med. 32:101–107. 2013.PubMed/NCBI
|
|
35
|
Haura EB, Turkson J and Jove R: Mechanisms
of disease: insights into the emerging role of signal transducers
and activators of transcription in cancer. Nat Clin Pract Oncol.
2:315–324. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yu H, Pardoll D and Jove R: STATs in
cancer inflammation and immunity: a leading role for STAT3. Nat Rev
Cancer. 9:798–809. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
37
|
Lu Y, Yue X, Cui Y, Zhang J and Wang K:
MicroRNA-124 suppresses growth of human hepatocellular carcinoma by
targeting STAT3. Biochem Biophys Res Commun. 441:873–879. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Li Y, Zhang Z, Liu X, et al: miR-124
functions as a tumor suppressor in the endometrial carcinoma cell
line HEC-1B partly by suppressing STAT3. Mol Cell Biochem.
388:219–231. 2014. View Article : Google Scholar
|
|
39
|
Wang MJ, Li Y, Wang R, et al:
Downregulation of microRNA-124 is an independent prognostic factor
in patients with colorectal cancer. Int J Colorectal Dis.
28:183–189. 2013. View Article : Google Scholar
|
|
40
|
Gebauer K, Peters I, Dubrowinskaja N, et
al: Hsa-mir-124–3 CpG island methylation is associated with
advanced tumours and disease recurrence of patients with clear cell
renal cell carcinoma. Br J Cancer. 108:131–138. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Berghmans T, Ameye L, Willems L, et al:
Identification of microRNA-based signatures for response and
survival for non-small cell lung cancer treated with
cisplatin-vinorelbine A ELCWP prospective study. Lung Cancer.
82:340–345. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Patnaik SK, Kannisto E, Knudsen S and
Yendamuri S: Evaluation of microRNA expression profiles that may
predict recurrence of localized stage I non-small cell lung cancer
after surgical resection. Cancer Res. 70:36–45. 2010. View Article : Google Scholar
|
